Survodutide Research Peptide — 1mg Lyophilized
Survodutide (BI 456906) is a synthetic dual GLP-1 receptor and glucagon receptor co-agonist peptide developed by Boehringer Ingelheim. It has been studied in published clinical research for its dual incretin and glucagonotropic activity. Its balanced GLP-1/glucagon receptor agonism provides a research tool for dissecting the complementary roles of GLP-1 and glucagon in metabolic regulation.
Research applications include receptor pharmacology profiling, hepatic lipid metabolism studies, beta-cell function assays, and comparative metabolic signaling research.
Research Specifications
- Molecular Weight: ~4,400 Da
- Purity: ≥98% (HPLC-MS)
- Storage: -20°C
⚠️ Research Use Only. Investigational compound. Not for human use.
